Chloe Botaine

Chloe Botaine

Biopharmaceutical Research Specialist
Chloe Botaine specializes in biopharmaceutical research and development, offering insights into the latest trends, challenges, and breakthroughs in biopharma. Her content covers topics such as drug discovery, clinical trials, and regulatory affairs. With a focus on advancing science and improving patient care, Chloe’s content contributes to the development of innovative therapies and medicines that address unmet medical needs and improve public health outcomes.
India's DBT and BIRAC Launch Bio-AI Proposal Drive
Tech & Innovation India's DBT and BIRAC Launch Bio-AI Proposal Drive

In a significant stride toward revolutionizing biotechnology, India's Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC) have jointly launched a call for proposals in the dynamic field of Bio-AI. This initiative is an integral part of the nation’s

Can 3D Collagen Scaffolds Transform Tissue Engineering?
Biotech & Bioprocessing Can 3D Collagen Scaffolds Transform Tissue Engineering?

In recent years, the field of tissue engineering has witnessed groundbreaking advancements, one of which is the development of 3D-printed collagen scaffolds by researchers at the University of Pittsburgh. This innovative technology, named CHIPS—collagen-based, high-resolution, internally perfusable

Are Novel Cancer Therapies Revolutionizing Patient Care?
Research & Development Are Novel Cancer Therapies Revolutionizing Patient Care?

In an era increasingly defined by scientific breakthroughs, the landscape of cancer treatment is witnessing transformative changes poised to revolutionize patient care. Recent developments, including innovative trials presented at The University of Texas MD Anderson Cancer Center during the AACR

SENTI-202 Shows Promise for AML Remission with CAR NK Therapy
Research & Development SENTI-202 Shows Promise for AML Remission with CAR NK Therapy

The development of SENTI-202, which leverages engineered chimeric antigen receptor natural killer (CAR NK) cells, signifies a significant advancement in the treatment landscape for relapsed or refractory acute myeloid leukemia (AML). Presented at the American Association for Cancer Research Annual

Optimizing Pumps for Scalable Alternative Protein Production
Biotech & Bioprocessing Optimizing Pumps for Scalable Alternative Protein Production

As the alternative protein industry strives to capture a significant share of the global protein market by 2035, optimizing bioprocessing emerges as a critical task. In an era where innovation is driven by sustainability and efficiency, manufacturers find themselves relying heavily on pump

States Tackle AI in Healthcare: Balancing Innovation and Safety
Management & Regulatory States Tackle AI in Healthcare: Balancing Innovation and Safety

The rapid integration of artificial intelligence (AI) into healthcare settings across the United States presents significant opportunities and profound challenges. Legislative approaches to regulating AI in healthcare are diverse, reflecting the complex needs of balancing patient safety with

Nuclivision Raises €5M to Revolutionize PET Scans with AI
Tech & Innovation Nuclivision Raises €5M to Revolutionize PET Scans with AI

The medical industry constantly seeks advancements that improve patient care and diagnostic accuracy while reducing costs and risks. Belgian medtech startup Nuclivision has secured €5M in funding aimed at revolutionizing medical imaging through the integration of artificial intelligence and

Can Blood Pressure Control Lower Dementia Risk?
Tech & Innovation Can Blood Pressure Control Lower Dementia Risk?

The link between blood pressure management and the reduction of dementia risk has been the subject of recent scientific inquiry. With the aging global population, dementia has become a significant public health concern, particularly in communities with high rates of hypertension. A recent study by

Can Gene Editing Cure Chronic Hepatitis B?
Research & Development Can Gene Editing Cure Chronic Hepatitis B?

With over 300 million people globally suffering from chronic hepatitis B, the disease presents a monumental challenge in the realm of public health. Traditional treatments have mainly focused on suppressing the virus rather than providing a cure, demanding lifelong therapy for many patients.

Can Focused Ultrasound Revolutionize Metastatic Breast Cancer Therapy?
Research & Development Can Focused Ultrasound Revolutionize Metastatic Breast Cancer Therapy?

Metastatic breast cancer remains one of the most challenging forms of cancer to treat, with only about one-third of patients surviving beyond five years post-diagnosis. Traditional treatments such as chemotherapy, radiation, and surgery have shown limited effectiveness, often accompanied by

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later